Matson, Inc.

Fundamentals7.2
Price Action6.0
News Sentiment8.0
AI Rating
7.4

Key Drivers

  • Strong margins
  • Weak liquidity
  • FCF setback

AI
AI Summary

7.4

MATX has shifted from a steady shipping cash-return story to a higher-expectation momentum trade driven by unusually strong China/trans-Pacific demand, but with free cash flow turning negative, thin liquidity, and valuation now stretched, the key takeaway is that upside depends on sustaining this earnings surge rather than simply posting another decent quarter.

Momentum
Cyclical
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.2

Key Financial Insights:

  • Strong margins
  • Weak liquidity
  • FCF setback

MATX remains highly profitable and cash-generative with moderate leverage, but weak liquidity and a recent free-cash-flow decline temper the case despite still-reasonable valuation.

profitability
liquidity

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Rebound support
  • Resistance stall
  • Range-bound action

MATX rebounded from its late-July low and is only slightly weaker over the last month, but with $218-$223 resistance still holding, the stock remains range-bound until buyers break that ceiling.

rangebound
watchlist
Support Level: $202-$205
Resistance Level: $218-$223

Sharp rebound from the late-July low near $201.47, but price has repeatedly stalled below resistance

Sentiment & News

8.0

Key News Insights:

  • Strong Q2 beat
  • Raised outlook
  • Buying momentum

Matson's latest headlines point to strong earnings momentum, a raised outlook, and improving analyst/investor sentiment as China service strength and technical support drive renewed upside.

EarningsBeat
BullishUpgrade

The news is net positive for MATX, signaling improving fundamentals and sentiment that could support further share-price upside